Future Vaccine Manufacturing Research Hub (Vax-Hub) Receives £12 Million Funding
11 May 2023
The Future Vaccine Manufacturing Research Hub (Vax-Hub), led by Professor Martina Micheletti (UCL Biochemical Engineering) and Professor Dame Sarah Gilbert (University of Oxford, Pandemic Sciences Institute), has been awarded £ 12 million over 7 years.
Formed in April 2018, the Future Vaccine Manufacturing Research Hub (Vax-Hub) is an academic collaboration led by UCL Biochemical Engineering and the University of Oxford. Co-directed by Professor Martina Micheletti (UCL) and Professor Dame Sarah Gilbert (Oxford), Vax-Hub comprises world-leading experts in vaccinology, synthetic biology, biochemical, materials, and system engineering.
This funding will enable the rapid rollout of highly effective new vaccines for frontline use. The hub, a follow-on from Vax-Hub1, aims to have a significant impact on global health security through the research and development of sustainable vaccine manufacturing technologies.
Find out more about Vax Hub here
Read More
- UKRI Announcement: Vaccine and food manufacturing hubs will save lives and cut carbon
- UCL News: Major funding boost for UCL-led vaccines hub
- Pandemic Sciences Institute (Oxford) News: £12 million investment for Future Vaccines Manufacturing Hub